SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hamid Ullah Wani, Saad Al Kaabi, Manik Sharma, Rajvir Singh, Anil John, Moutaz Derbala, Muneera J. Al-Mohannadi, High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B, Hepatitis Research and Treatment, 2014, 2014, 1

    CrossRef

  2. 2
    A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse, H. L.-Y. Chan, Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir, Alimentary Pharmacology & Therapeutics, 2011, 34, 8
  3. 3
    George V. Papatheodoridis, Pietro Lampertico, Spilios Manolakopoulos, Anna Lok, Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review, Journal of Hepatology, 2010, 53, 2, 348

    CrossRef

  4. 4
    Marc G. Ghany, Edward C. Doo, Antiviral resistance and hepatitis B therapy, Hepatology, 2009, 49, S5
  5. 5
    Spilios Manolakopoulos, Christos Triantos, Jiannis Theodoropoulos, Jiannis Vlachogiannakos, Anastasios Kougioumtzan, George Papatheodoridis, Dimitrios Tzourmakliotis, Dimitrios Karamanolis, Andrew K. Burroughs, Athanasios Archimandritis, Sotirios Raptis, Alec Avgerinos, Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension, Journal of Hepatology, 2009, 51, 3, 468

    CrossRef

  6. 6
    O. Koch, S. Sheehy, R. Serafino, B.J. Angus, 2009,

    CrossRef

  7. 7
    S. MANOLAKOPOULOS, S. BETHANIS, S. KOUTSOUNAS, J. GOULIS, J. VLACHOGIANNAKOS, E. CHRISTIAS, A. SAVERIADIS, C. PAVLIDIS, C. TRIANTOS, A. CHRISTIDOU, G. PAPATHEODORIDIS, D. KARAMANOLIS, D. TZOURMAKLIOTIS, Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine, Alimentary Pharmacology & Therapeutics, 2008, 27, 3
  8. 8
    Nancy Leung, Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues, Hepatology International, 2008, 2, 2, 163

    CrossRef

  9. 9
    George V Papatheodoridis, Melanie Deutsch, Resistance issues in treating chronic hepatitis B, Future Microbiology, 2008, 3, 5, 525

    CrossRef

  10. 10
    George V Papatheodoridis, Spilios Manolakopoulos, Geoffrey Dusheiko, Athanasios J Archimandritis, Therapeutic strategies in the management of patients with chronic hepatitis B virus infection, The Lancet Infectious Diseases, 2008, 8, 3, 167

    CrossRef

  11. 11
    Annika Kau, Johannes Vermehren, Christoph Sarrazin, Treatment predictors of a sustained virologic response in hepatitis B and C, Journal of Hepatology, 2008, 49, 4, 634

    CrossRef